Effect of pegylated interferon-α2b add-on therapy on renal function in chronic hepatitis b patients: a real-world experience

HIGHLIGHTS

• who: Ying Guo and Ye Zhang from the Suzhou Municipal Hospital, China Sichuan University, China have published the Article: Effect of pegylated interferon-u03b12b add-on therapy on renal function in chronic hepatitis B patients: A real-world experience, in the Journal: (JOURNAL)
• what: The authors aimed to assess the change of renal function under PEG-IFNu03b12b (Y shape, 40 kD) add-on therapy to ETV in CHB patients.
• how: The results showed that female gender baseline sCr and PEG-IFNu03b12b add-on were significant positive predictors for eGFR elevation at 24 and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.